Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in XLO — Xilio Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to XLO Full portfolio

Position in XLO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$374,146
+$61,321 QoQ
Shares Held
39,055
+5.0% QoQ
Ownership
0.675%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 26 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. XLO ranks #372 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in XLO

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $374,146 39,055
2026-03-31 $312,825 37,197
2025-12-31 $210,542 328,972
2025-09-30 $277,322 328,972
2025-06-30 $251,368 369,660
2025-03-31 $274,407 379,016
2024-12-31 $342,292 358,422
2024-09-30 $266,494 338,192
2024-06-30 $173,345 182,855
2024-03-31 $91,612 84,826
2023-12-31 $46,654 84,826
2023-09-30 $178,982 84,826
2023-06-30 $221,982 84,726
2023-03-31 $268,581 84,726
2022-12-31 $227,912 84,726
2022-09-30 $243,243 83,589
2022-06-30 $244,079 83,589
2022-03-31 $1,001,889 141,710
2021-12-31 $2,146,959 134,185